Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 988-991

  Takatani, Hiroshi ^a   Soda, Hiroshi ^a   Fukuda, Masaaki ^a   Watanabe, Masami ^a   Kinoshita, Akitoshi ^a   Nakamura, Tsuyoshi ^a   Oka, Mikio ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINDESINE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG CANCER; MALE; NEUTROPENIA; NEUTROPHIL; NEUTROPHILIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029976203     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.988     Document Type: Article

References (27)

1. American Society of Clinical Oncology. 1994. American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin. Oncol. 12:2471-2508.
2. Bartocci, A., D. S. Mastrogiannis, G. Migliorati, R. J. Stockert, and A. W. Wolkoff. 1987. Macrophages specifically regulate the concentration of their own growth factor in the circulation Proc. Natl. Acad Sci. USA 84:6179-6183.
3. Bukowski, R. M., G. T. Budd, J. A. Gibbons, R. J. Bauer, A. Childs, J. Antal, J. Finke, L. Tuason, V. Lorenzi, D. Mclain, R. Tubbs, M. Edinger, and M. J. Thomassen. 1994. Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor clinical and immunomodulatory effects. J. Clin. Oncol. 12:97-106.
4. Cebon, J., J. E. Layton, D. Maher, and G. Morstyn. 1994. Endogenous haemopoietic growth factors in neutropenia and infection. Br. J. Haematol. 86:265-274.
5. Cebon, J. S., R. W. Bury, G. J. Lieschke. and G. Morstyn. 1990. The effects of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor. Eur. J. Cancer 26:1064-1069.
6. Chugai-Rhône-Poulenc. 1994. Granocyte (lenograstim). Chugai-Rhônc-Poulenc, Antony, France. (Package insert.)
7. Demetri, G. D., and J. D. Griffin. 1991. Granulocyte colony-stimulating factor and its receptor. Blood 78:2791-2808.
8. Draper, N. R., and H. Smith. 1981. Applied regression analysis. Wiley, New York.
9. Eguchi, K., T. Shinkai, Y. Sasaki, T. Tamura, Y. Ohe, K. Nakagawa, M. Fukuda, K. Yamada, A. Kojima, F. Oshita, M. Morita, K. Suemasu, and N. Saijo. 1990. Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN 8601) in intensive chemotherapy for patients with advanced lung cancer. Jpn. J. Cancer Res. 81:1168-1174.
10. 125I-r-G-CSF in rats. Yakuri to Chiryo 18:52629-52640. (In Japanese.)
11. Kinoshita. H., M. Kato, J. Amano, Y. Hiramatsu, K. Okano, N. Oh-ishi, A. Okazaki, T. Tatsumi, M. Koto, and J. Adachi. 1990. Metabolic fate of rhG-CSF (1): pharmacokinetics of rhG-CSF in rats, dogs and monkeys. Yakuri to Chiryo 18:S2615-S2623. (In Japanese.)
12. Layton, J. E., H. Hockman, W. P. Sheridan, and G. Morstyn. 1989 Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood 74:1303-1307.
13. Ludwig, H., E. Fritz, C. Leitgeb, M. Pecherstorfer, H. Samonigg, and J. Schuster. 1994. Prediction of response to crythropoietin treatment in chronic anemia of cancer. Blood 84:1056-1063.
14. Motojima, H., T. Kobayashi, M. Shimane, S. Kamachi, and M. Fukushima. 1989 Quantitative enzyme immunoassay for human granulocyte colony stimulating factor (G-CSF). J. Immunol. Methods 118:187-192
15. Mountain, C. F. 1986 A new international staging system for lung cancer. Chest 89(Suppl.):225S-233S.
16. Nicola, N. A., L. Peterson, D. J. Hilton, and D. Metcalf. 1988. Cellular processing of marine colony-stimulating factor (multi-CSF, GM-CSF, G-CSF) receptor by normal hemopoietic cells and cell lines. Growth Factors 1: 41-49.
17. Nissen, C., V. D. Carbonare, and Y. Moser. 1994. In vitro comparison of the biological potency of glycosylated versus nonglycosylated rhG-CSF. Drug Invest. 7:346-352.
18. Ota, K., Y. Ariyoshi, M. Fukuoka, K. Furuse, and H. Niitani. 1990. Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for lung cancer. Jpn. J. Cancer Chemother. 17:65-71. (In Japanese.)
19. Pauksen, K., L. Elfman, A. Ulfgren, and P. Venge. 1994. Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and atypical pneumonia Br. J. Haematol. 88:256-260.
20. Redman, B. G., L. Flaherty, T. H. Chou, M. Kraut, S. Martino, M. Simon, M. Valdivieso, and E. Groves. 1992 Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancer. J Immunother. 12:50-54
21. Soda, II., M. Oka, M. Fukuda, A. Kinoshita, A. Sakamoto, J. Araki, S. Fujino, N. Itoh, K. Watanabe, T. Kanda, M. Nakano, and K. Hara. 1996 Optimal schedule for administering granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in non-small-cell lung cancer. Cancer Chemother. Pharmacol. 38:9-12
22. Stute, N., V. M. Santana, J. H. Rodman, M. J. Schell, J. N. Ihle, and W. E. Evans. 1992. Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. Blood 79:2849-2854.
23. Tanaka, H., and T. Tokiwa. 1990. Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN 8601) in the rat. Cancer Res. 50:6615-6619.
24. Watari, K., S. Asano, N. Shirafuji, H. Kodo, K. Ozawa, F. Takaku, and S. Komachi. 1989. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73:117-122.
25. World Health Organization. 1982 The World Health Organization histological typing of lung tumors, ed. 2. Am J. Clin. Pathol. 77:123-136.
26. Wright, D. G., A. L. Meierovics, and J. M. Foley. 1986. Assessing the delivery of neutrophils to tissues in neutropenia. Blood 67:1023-1030.
27. Zubrod, G. C., M. Schneiderman, and E. Frei III. 1960. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylenethiophosphoramide. J. Chronic Dis. 11:7-33